These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34784462)

  • 1. Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation.
    Wright L; Joyce P; Barnes TJ; Prestidge CA
    ACS Biomater Sci Eng; 2023 Jun; 9(6):2819-2837. PubMed ID: 34784462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems.
    Wright L; Wignall A; Jõemetsa S; Joyce P; Prestidge CA
    Drug Deliv Transl Res; 2023 Apr; 13(4):1088-1101. PubMed ID: 36520273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
    Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
    J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucus models to evaluate the diffusion of drugs and particles.
    Lock JY; Carlson TL; Carrier RL
    Adv Drug Deliv Rev; 2018 Jan; 124():34-49. PubMed ID: 29117512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucus as a barrier to lipophilic drugs.
    Sigurdsson HH; Kirch J; Lehr CM
    Int J Pharm; 2013 Aug; 453(1):56-64. PubMed ID: 23727593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mucus in cell-based models used to screen mucosal drug delivery.
    Lechanteur A; das Neves J; Sarmento B
    Adv Drug Deliv Rev; 2018 Jan; 124():50-63. PubMed ID: 28751201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus.
    Wright L; Barnes TJ; Joyce P; Prestidge CA
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Functional Properties of Intestinal Mucus Layer in Poultry.
    Duangnumsawang Y; Zentek J; Goodarzi Boroojeni F
    Front Immunol; 2021; 12():745849. PubMed ID: 34671361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.
    Watchorn J; Clasky AJ; Prakash G; Johnston IAE; Chen PZ; Gu FX
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1396-1426. PubMed ID: 35294187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models to evaluate the barrier properties of mucus during drug diffusion.
    Liu L; Tian C; Dong B; Xia M; Cai Y; Hu R; Chu X
    Int J Pharm; 2021 Apr; 599():120415. PubMed ID: 33647411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mucus on drug transport and its potential to affect therapeutic outcomes.
    Murgia X; Loretz B; Hartwig O; Hittinger M; Lehr CM
    Adv Drug Deliv Rev; 2018 Jan; 124():82-97. PubMed ID: 29106910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Oral Absorption of fenofibrate in Lipid-Based Drug Delivery Systems by Combining In Vitro Lipolysis with the Mucus-PVPA Permeability Model.
    Falavigna M; Klitgaard M; Berthelsen R; Müllertz A; Flaten GE
    J Pharm Sci; 2021 Jan; 110(1):208-216. PubMed ID: 32916137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?
    Pearson JP; Chater PI; Wilcox MD
    Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.
    Boegh M; García-Díaz M; Müllertz A; Nielsen HM
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):136-43. PubMed ID: 25622791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
    Falavigna M; Klitgaard M; Steene E; Flaten GE
    Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer.
    Loftsson T
    Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simple
    Mokszycki ME; Leatham-Jensen M; Steffensen JL; Zhang Y; Krogfelt KA; Caldwell ME; Conway T; Cohen PS
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30291119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental models to study intestinal microbes-mucus interactions in health and disease.
    Etienne-Mesmin L; Chassaing B; Desvaux M; De Paepe K; Gresse R; Sauvaitre T; Forano E; de Wiele TV; Schüller S; Juge N; Blanquet-Diot S
    FEMS Microbiol Rev; 2019 Sep; 43(5):457-489. PubMed ID: 31162610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undefined role of mucus as a barrier in ocular drug delivery.
    Ruponen M; Urtti A
    Eur J Pharm Biopharm; 2015 Oct; 96():442-6. PubMed ID: 25770770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.